Matthew R Patterson

CIK 1401018 · Chief Executive Officer · last filed 2025-05-23

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$0

Companies

5

Total Filings

54

Lifetime Open-Market Net

-$8.41M

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
VOR Director $14.36 $0 5 2025-05-23
Q32 Bio Inc. (FIXX) Delisted Director $16.82 $0 6 2023-06-15
5:01 Acquisition Corp. (FVAM) Delisted Director $10.00 $0 1 2020-10-20
BOLD Chief Executive Officer 0 $1.41 $0 -$7.92M 21 2020-01-15
AMICUS THERAPEUTICS, INC. (FOLD) Delisted Acting CEO & President 106,547 $14.49 $1.54M -$489.4K 21 2011-04-19

Recent Filings · Page 6 of 6

54 filings
Form 4 transactions across all companies, newest first.
Filed Symbol Action Net Shares Net $ Link
2008-04-16 AMICUS THERAPEUTICS, INC. (FOLD) Delisted Sell (S) −4,500 -$45.8K EDGAR
2008-02-25 AMICUS THERAPEUTICS, INC. (FOLD) Delisted Exer (M) +12,083 $7.7K EDGAR
2008-02-07 AMICUS THERAPEUTICS, INC. (FOLD) Delisted Grant (A) $0 EDGAR
2007-08-28 AMICUS THERAPEUTICS, INC. (FOLD) Delisted Exer (M) +32,366 $20.6K EDGAR
Showing 5154 of 54
Page 6 of 6
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.